Free Trial

Veru (VERU) Competitors

Veru logo
$0.98 +0.13 (+15.61%)
Closing price 04:00 PM Eastern
Extended Trading
$0.96 -0.01 (-1.27%)
As of 07:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VERU vs. NUS, NATR, MED, EL, IPAR, PBH, HLF, USNA, ESPR, and SIGA

Should you be buying Veru stock or one of its competitors? The main competitors of Veru include Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Estée Lauder Companies (EL), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Herbalife (HLF), USANA Health Sciences (USNA), Esperion Therapeutics (ESPR), and SIGA Technologies (SIGA).

Veru vs.

Nu Skin Enterprises (NYSE:NUS) and Veru (NASDAQ:VERU) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends, profitability and community ranking.

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 47.2% of Veru shares are owned by institutional investors. 1.7% of Nu Skin Enterprises shares are owned by insiders. Comparatively, 14.2% of Veru shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Nu Skin Enterprises has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nu Skin Enterprises$1.97B0.18$8.60M-$2.07-3.38
Veru$16.89M8.45-$37.80M-$0.28-3.48

Nu Skin Enterprises has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Comparatively, Veru has a beta of -0.53, suggesting that its share price is 153% less volatile than the S&P 500.

Nu Skin Enterprises received 239 more outperform votes than Veru when rated by MarketBeat users. However, 69.82% of users gave Veru an outperform vote while only 63.92% of users gave Nu Skin Enterprises an outperform vote.

CompanyUnderperformOutperform
Nu Skin EnterprisesOutperform Votes
512
63.92%
Underperform Votes
289
36.08%
VeruOutperform Votes
273
69.82%
Underperform Votes
118
30.18%

Nu Skin Enterprises has a net margin of -5.81% compared to Veru's net margin of -223.85%. Nu Skin Enterprises' return on equity of 5.47% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
Nu Skin Enterprises-5.81% 5.47% 2.46%
Veru -223.85%-92.88%-55.83%

Nu Skin Enterprises presently has a consensus target price of $6.88, suggesting a potential downside of 1.86%. Veru has a consensus target price of $4.00, suggesting a potential upside of 310.09%. Given Veru's stronger consensus rating and higher probable upside, analysts clearly believe Veru is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nu Skin Enterprises
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Veru
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Nu Skin Enterprises had 2 more articles in the media than Veru. MarketBeat recorded 9 mentions for Nu Skin Enterprises and 7 mentions for Veru. Veru's average media sentiment score of 0.83 beat Nu Skin Enterprises' score of 0.47 indicating that Veru is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nu Skin Enterprises
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Veru
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Nu Skin Enterprises beats Veru on 10 of the 18 factors compared between the two stocks.

Get Veru News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERU vs. The Competition

MetricVeruPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$142.78M$6.58B$5.36B$9.14B
Dividend YieldN/A2.94%5.13%4.04%
P/E Ratio-3.489.8389.4717.33
Price / Sales8.45305.871,263.70136.49
Price / CashN/A61.4443.7535.97
Price / Book4.436.055.324.80
Net Income-$37.80M$154.62M$122.60M$224.91M
7 Day Performance24.76%-1.68%0.69%1.77%
1 Month Performance36.74%-2.35%1.55%2.22%
1 Year Performance123.25%1.02%27.25%20.67%

Veru Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERU
Veru
2.3477 of 5 stars
$0.98
+15.6%
$4.00
+310.1%
+102.9%$142.78M$16.89M-3.48230High Trading Volume
NUS
Nu Skin Enterprises
3.7433 of 5 stars
$6.89
+10.8%
$6.88
-0.2%
-60.7%$342.51M$1.78B-3.333,700Short Interest ↓
NATR
Nature's Sunshine Products
3.9232 of 5 stars
$13.98
-1.7%
$19.00
+35.9%
-20.1%$258.29M$445.10M15.89850Positive News
MED
Medifast
1.8979 of 5 stars
$15.33
-3.0%
$17.00
+10.9%
-72.0%$167.68M$674.48M23.23870
EL
Estée Lauder Companies
4.5559 of 5 stars
$74.85
+1.9%
$96.50
+28.9%
-39.9%$26.87B$15.45B133.6662,000Analyst Forecast
Short Interest ↑
News Coverage
IPAR
Inter Parfums
4.229 of 5 stars
$128.50
-0.3%
$159.75
+24.3%
+0.3%$4.12B$1.42B27.58530Analyst Forecast
News Coverage
PBH
Prestige Consumer Healthcare
3.553 of 5 stars
$74.80
+1.1%
$85.25
+14.0%
+32.7%$3.70B$1.11B18.20540Analyst Downgrade
Analyst Revision
News Coverage
HLF
Herbalife
4.6118 of 5 stars
$6.57
-0.3%
$9.90
+50.7%
-48.0%$662.20M$5.00B7.739,200Short Interest ↑
USNA
USANA Health Sciences
4.5497 of 5 stars
$34.21
+1.0%
$38.00
+11.1%
-30.1%$652.04M$861.97M12.091,900
ESPR
Esperion Therapeutics
4.0944 of 5 stars
$2.21
-5.6%
$7.30
+230.3%
-19.6%$435.45M$295.45M-3.45200Short Interest ↑
Gap Down
SIGA
SIGA Technologies
1.9041 of 5 stars
$6.06
-2.4%
N/A+19.5%$432.71M$173.73M5.0540Positive News

Related Companies and Tools


This page (NASDAQ:VERU) was last updated on 1/17/2025 by MarketBeat.com Staff
From Our Partners